Abstract
ObjectiveTo evaluate the effects and reliability of alfaxalone constant rate infusion (CRI) in comparison to isoflurane to maintain anaesthesia in bitches undergoing elective caesarean section. Study designProspective, randomized, ‘blinded’ clinical trial. AnimalsTwenty-two client-owned bitches and 94 puppies. MethodsBitches were randomly assigned to receive an alfaxalone CRI [0.2 mg kg-1 minute-1 intravenously (IV), and once the last puppy was delivered, the dose was halved; n = 11] or 2% (vaporizer dial setting) isoflurane (n = 11) for maintenance of anaesthesia. All dogs were induced with alfaxalone (3 mg kg-1) IV. Additional alfaxalone (0.3 mg kg-1 IV) was administered if the depth of anaesthesia was inadequate and the total dose was calculated. Bitches were mechanically ventilated. Analgesia was administered after the delivery of puppies. Physiological variables were recorded every 5 minutes. The bitches’ recovery times were also recorded. Quality of induction and recovery were evaluated. Puppies’ vigour was evaluated with a modified Apgar score at 5 and 60 minutes after birth. Puppies’ survival rates at 24 and 48 hours and at 15 days were recorded. Data were analysed using an anova, Student’s t-test or Wilcoxon rank-sum test. ResultsThe rescue dose of alfaxalone was higher (p = 0.01); bitches’ recoveries were longer (p < 0.001) and puppies’ Apgar scores were significantly lower at 5 and 60 minutes (p < 0.001 and p = 0.003, respectively) with alfaxalone than with isoflurane. However, no significant differences were found for puppies’ survival between groups. Conclusions and clinical relevanceAlfaxalone CRI seems to be a possible protocol for puppies and bitches undergoing elective caesarean sections. However, bitches recovered more slowly and puppy Apgar scores were lower in comparison to isoflurane.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.